|
|
||||||||
1


*
Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Department of Medicine, Harvard Medical School, Boston, MA 02215; and
GlaxoSmithKline, King of Prussia, PA 19406
IL-18 is a Th1 cytokine that synergizes with IL-12 and IL-2 in the
stimulation of lymphocyte IFN-
production. IL-18 binding protein
(IL-18BP) is a recently discovered inhibitor of IL-18 that is distinct
from the IL-1 and IL-18 receptor families. In this report we show that
IL-18BPa, the IL-18BP isoform with the highest affinity for IL-18, was
strongly induced by IL-12 in human PBMC. Other Th1 cytokines, including
IFN-
, IL-2, IL-15, and IL-18, were also capable of augmenting
IL-18BPa expression. In contrast, IL-1
, IL-1
, TNF-
,
IFN-
-inducible protein-10, and Th2 cytokines such as IL-4 and IL-10
did not induce IL-18BPa. Although monocytes were found to be the
primary source of IL-18BPa, the induction of IL-18BPa by IL-12 was
mediated through IFN-
derived predominantly from NK cells. IL-18BPa
production was observed in cancer patients receiving recombinant human
IL-12 and correlated with the magnitude of IFN-
production. The
IFN-
/IL-18BPa negative feedback loop identified in this study may be
capable of broadly controlling immune activation by cytokines that
synergize with IL-18 to induce IFN-
and probably plays a key role in
the modulation of both innate and adaptive
immunity.
This article has been cited by other articles:
![]() |
C. F. Fortin, T. Ear, and P. P. McDonald Autocrine role of endogenous interleukin-18 on inflammatory cytokine generation by human neutrophils FASEB J, January 1, 2009; 23(1): 194 - 203. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Robertson, J. W. Mier, T. Logan, M. Atkins, H. Koon, K. M. Koch, S. Kathman, L. N. Pandite, C. Oei, L. C. Kirby, et al. Clinical and biological effects of recombinant human interleukin-18 administered by intravenous infusion to patients with advanced cancer. Clin. Cancer Res., July 15, 2006; 12(14): 4265 - 4273. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Alberti, T. Bachelot, A. Duc, C. Biota, and J. Y. Blay A Spliced Isoform of Interleukin 6 mRNA Produced by Renal Cell Carcinoma Encodes for an Interleukin 6 Inhibitor Cancer Res., January 1, 2005; 65(1): 2 - 5. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gatto, C. Berlato, V. Poli, S. Tininini, I. Kinjyo, A. Yoshimura, M. A. Cassatella, and F. Bazzoni Analysis of SOCS-3 Promoter Responses to Interferon {gamma} J. Biol. Chem., April 2, 2004; 279(14): 13746 - 13754. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. Banda, A. Vondracek, D. Kraus, C. A. Dinarello, S.-H. Kim, A. Bendele, G. Senaldi, and W. P. Arend Mechanisms of Inhibition of Collagen-Induced Arthritis by Murine IL-18 Binding Protein J. Immunol., February 15, 2003; 170(4): 2100 - 2105. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |